摘要:
sci-hub.se 参考文章(74)
S. M�nard, P. Casalini, M. Campiglio, S. M. Pupa, E. Tagliabue, Role of HER2/neu in Tumor Progression and Therapy Cellular and Molecular Life Sciences. ,vol. 61, pp. 2965- 2978 ,(2004) , 10.1007/S00018-004-4277-7
S. Del Vecchio, Leonardo Pace, M. Salvatore, R. Fonti, A. Zannetti, Nuclear imaging in cancer theranostics. Quarterly Journal of Nuclear Medicine and Molecular Imaging. ,vol. 51, pp. 152- 163 ,(2007)
A. L. Baert, Encyclopedia of diagnostic imaging Springer. ,(2008)
Maha Saad, Olga B. Garbuzenko, Elizabeth Ber, Pooja Chandna, Jayant J. Khandare, Vitaly P. Pozharov, Tamara Minko, Receptor targeted polymers, dendrimers, liposomes: which nanocarrier is the most efficient for tumor-specific treatment and imaging? Journal of Controlled Release. ,vol. 130, pp. 107- 114 ,(2008) , 10.1016/J.JCONREL.2008.05.024
Daniela Delli Castelli, Eliana Gianolio, Simonetta Geninatti Crich, Enzo Terreno, Silvio Aime, Metal containing nanosized systems for MR-Molecular Imaging applications Coordination Chemistry Reviews. ,vol. 252, pp. 2424- 2443 ,(2008) , 10.1016/J.CCR.2008.05.006
Lawrence E. Williams, George Lopatin, Daniel D. Kaplan, An Liu, Jeffrey Y.C. Wong, Review: update on selection of optimal radiopharmaceuticals for clinical trials. Cancer Biotherapy and Radiopharmaceuticals. ,vol. 23, pp. 797- 806 ,(2008) , 10.1089/CBR.2008.0534
Lawrence E. Williams, Anna M. Wu, Paul J. Yazaki, An Liu, Andrew A. Raubitschek, John E. Shively, Jeffrey Y.C. Wong, Numerical Selection of Optimal Tumor Imaging Agents with Application to Engineered Antibodies Cancer Biotherapy and Radiopharmaceuticals. ,vol. 16, pp. 25- 35 ,(2001) , 10.1089/108497801750095989
Valentina Ambrosini, Carmelo Quarta, Cristina Nanni, Cinzia Pettinato, Roberto Franchi, Gaia Grassetto, Adil Al-Nahhas, Stefano Fanti, Domenico Rubello, Small Animal PET in Oncology: The Road from Bench to Bedside Cancer Biotherapy and Radiopharmaceuticals. ,vol. 24, pp. 277- 285 ,(2009) , 10.1089/CBR.2008.0554
Ralph Weissleder, Mikael J. Pittet, Imaging in the era of molecular oncology Nature. ,vol. 452, pp. 580- 589 ,(2008) , 10.1038/NATURE06917
Emily Gullotti, Yoon Yeo, Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery. Molecular Pharmaceutics. ,vol. 6, pp. 1041- 1051 ,(2009) , 10.1021/MP900090Z